Physician profile
Sara Baker
NPI 1659757946
$574.89
in general payments reported to CMS, 2019-2025
15 companies · $78.25 in 2025
The $78.25 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.09 · 2022: $50.30 · 2023: $195 · 2024: $154 · 2025: $78.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.45 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $142.58 | 2023-2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $53.00 | 2022-2023 | Twirla |
| Hologic Sales and Service, LLC | $47.12 | 2024 | Thinprep 2000 Processor, Aptima |
| Biohaven Pharmaceuticals, INC. | $46.03 | 2021 | |
| Organon LLC | $42.47 | 2021-2025 | Nexplanon |
| Millicent US INC | $40.05 | 2023 | Femring |
| Takeda Pharmaceuticals U.S.A., INC. | $34.31 | 2024 | Fruzaqla |
| Dexcom, INC. | $30.62 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Shield Therapeutics INC | $30.56 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $27.29 | 2025 | |
| Evofem Biosciences, INC. | $17.17 | 2022 | |
| Merck Sharp & Dohme LLC | $17.04 | 2024 | Gardasil, Vaxneuvance, Gardasil 9 |
| Glaxosmithkline, LLC. | $16.72 | 2022 | |
| Cranial Technologies, INC | $15.23 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.